Emergent BioSolutions | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2025-03
ALKERMES USD 1.8M 35K 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amarin USD 308.15M 2.85M 2025-03
ANI Pharmaceuticals USD 2K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Exact Sciences USD 1.89M 30K 2025-03
Exelixis USD 275K 7K 2025-04
Glaxosmithkline GBP 1.35B 0 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
Ironwood Pharmaceuticals USD 160K 0 2024-12
Lonza CHF 72M 0 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Myriad Genetics USD 900K 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pacira USD 47K 0 2025-03
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
United Therapeutics USD 800K 0 2025-03



Emergent BioSolutions Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.